Search
for
Sort by
Research 30 of 1000+
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Cardiovascular risk factors in young Czech females with polycystic ovary syndrome
- Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- Cardiovascular risk factors and events in women with androgen excess
- Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis
- Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors?
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Cardiovascular effects of hormone therapy for prostate cancer
- Patients with vitiligo present fewer cardiovascular risk factors: results from a case–control study
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Cardiovascular toxicity of minoxidil in the marmoset
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk
- Cardiovascular Disease-Associated Skin Conditions
- Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia
- Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease
- Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: A case-control study
- Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Hutchinson-gilford progeria syndrome and its relevance to cardiovascular diseases and normal aging.
- Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
- Cardiovascular risk markers in premature canities
- Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age
- Low dose oral minoxidil and the conundrum of cardiovascular complications